Health Care & Life Sciences » Pharmaceuticals | Whanin Pharmaceutical Co. Ltd.

Whanin Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Whanin Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Low Priced Stock Fund
1,750,000
9.41%
0
0.1%
04/30/2018
IVA International Fund
1,161,012
6.24%
344,816
0.57%
12/31/2017
234,453
1.26%
0
1.19%
09/06/2018
CREF Stock Account
143,391
0.77%
0
0%
03/31/2018
DFA Emerging Markets Small Cap Series
120,322
0.65%
0
0.03%
01/31/2018
Fidelity Funds SICAV - Asian Smaller Companies Fund
108,801
0.59%
8,999
0.27%
05/31/2018
DFA Emerging Markets Core Equity Portfolio
98,586
0.53%
0
0.01%
04/30/2018
Government Pension Fund - Global (The)
78,240
0.42%
-15,609
0%
12/31/2017
56,381
0.3%
56,381
0.13%
11/24/2017
Fidelity Asian Values Plc
49,819
0.27%
7,139
0.27%
05/31/2018

About Whanin Pharmaceutical Co.

View Profile
Address
Whanin Building
Seoul SL 05809
Korea, Republic Of
Employees -
Website http://www.whanin.com
Updated 07/08/2019
Whan In Pharmaceutical Co., Ltd. engages in the manufacture and sale of medical supplies. Its products include psychotropic agent, medicine for circulating system and digestive ulcers, therapeutic for osteoporosis, pain killers, and others. The company was founded by Lee Kwang-Sik in June 1978 is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.